Ozempic Cost in Australia (2026): PBS, Private, and Every Pathway Compared

TL;DR: Ozempic costs $25 per script on the PBS for type 2 diabetes ($7.70 with a concession card). For weight loss, there's no PBS subsidy: private prescriptions run $130 to $220 per month depending on dose. Wegovy (higher-dose semaglutide for weight management) costs $350 to $450 per month. Mounjaro ranges from $285 to $429 per month. Telehealth platforms like Juniper bundle medication with consultations starting from $349 per month. Private health insurance offers minimal coverage: most insurers cap weight loss medication benefits at $60 to $150 per claim. Annual out-of-pocket costs for weight loss range from roughly $1,560 (off-label Ozempic) to $5,400 (Wegovy at maintenance dose).

The cost of semaglutide in Australia depends almost entirely on one question: are you using it for type 2 diabetes, or for weight loss?

If it's diabetes, Ozempic is one of the most affordable medications on the PBS. If it's weight loss, you're paying full private pricing with almost no subsidy. The gap between these two pathways is enormous: roughly $300 per year versus $1,500 to $5,400 per year.

This guide breaks down every cost pathway, compares all the available weight loss medications by price, and covers what private insurance actually covers (spoiler: very little). For a walkthrough of how to access these medications and who can prescribe them, see how to get Ozempic in Australia.

PBS Pricing: Ozempic for Type 2 Diabetes

The Pharmaceutical Benefits Scheme subsidises Ozempic for adults with type 2 diabetes who have inadequate blood sugar control despite metformin therapy.

What You Pay

| Patient Category | Cost Per Script | Annual Cost (12 scripts) | |---|---|---| | General patients | $25.00 | $300.00 | | Concession card holders | $7.70 | $92.40 | | Safety Net (general) | $7.70 | Varies | | Safety Net (concession) | Free | $0 |

Each script covers one pre-filled pen with a four-week supply (four weekly doses).

The PBS Safety Net

If your total PBS co-payments reach the Safety Net threshold in a calendar year, your costs drop further:

• General patients: After $1,748.20 in co-payments, you pay $7.70 per script for the rest of the year
• Concession card holders: After $277.20 in co-payments, all PBS scripts are free for the rest of the year

For someone only taking Ozempic, the general Safety Net threshold would take roughly 70 scripts to reach, so it's mainly relevant if you're filling multiple PBS medications. Concession card holders hit the threshold after about 36 scripts.

What It Would Cost Without PBS

The wholesale price of Ozempic before PBS subsidy is approximately $380 to $420 per pen. The PBS absorbs the vast majority of this cost for eligible patients. Without the scheme, Australians with diabetes would face the same pricing pressure seen in the United States, where semaglutide costs $900 to $1,000 USD per month without insurance. See how much Ozempic costs per month for the full US breakdown.

Private Pricing: Ozempic for Weight Loss

Ozempic is approved by the TGA only for type 2 diabetes. Using it for weight loss requires a private prescription written off-label by your doctor. The PBS does not apply, and you pay the full retail price.

Cost by Dose

| Dose | Monthly Cost (AUD) | Annual Cost (AUD) | |---|---|---| | 0.25mg (starter, weeks 1 to 4) | $130 to $150 | $1,560 to $1,800 | | 0.5mg (weeks 5 to 8) | $140 to $170 | $1,680 to $2,040 | | 1mg (maintenance) | $180 to $220 | $2,160 to $2,640 |

Pricing varies by pharmacy. Chemist Warehouse, Priceline Pharmacy, and TerryWhite Chemmart all stock Ozempic for private prescriptions, though prices can differ by $10 to $30 between chains for the same product. It's worth calling ahead to compare, especially for the 1mg maintenance dose you'll be on long-term.

The Pen Transition

Novo Nordisk is transitioning from the older 1.5mL Ozempic pen to a new 3mL pen. The 1.5mL format is available for dispensing until June 1, 2026, but no new prescriptions can be written for it. The 3mL pen covers the same doses and dosing schedule. Pricing is comparable.

Wegovy Pricing: The Weight Management Alternative

Wegovy is the TGA-approved semaglutide product specifically for weight management. It uses the same active ingredient as Ozempic but at doses up to 2.4mg weekly (compared to Ozempic's 1mg maximum).

Cost by Dose

| Dose | Weekly Schedule | Monthly Cost (AUD) | |---|---|---| | 0.25mg (weeks 1 to 4) | Starter | $320 to $350 | | 0.5mg (weeks 5 to 8) | Titration | $340 to $370 | | 1mg (weeks 9 to 12) | Titration | $360 to $390 | | 1.7mg (weeks 13 to 16) | Titration | $380 to $420 | | 2.4mg (week 17 onward) | Maintenance | $400 to $450 |

Annual costs at the maintenance dose: $4,800 to $5,400.

PBS Status

Wegovy is currently in PBS price negotiations following a PBAC recommendation. The initial listing, if approved, would cover only patients with established cardiovascular disease and a BMI of 35 or above (32.5 for certain ethnic backgrounds). The listing date has not been confirmed. Most people seeking Wegovy for weight loss without cardiovascular disease will continue paying full private pricing even after the PBS listing goes live.

Ozempic vs Wegovy: Which Is Cheaper?

Off-label Ozempic is significantly cheaper than Wegovy: $130 to $220 per month versus $320 to $450. The trade-off is dose. Ozempic maxes out at 1mg weekly, while Wegovy goes to 2.4mg. Clinical data shows higher semaglutide doses produce more weight loss (approximately 15% average body weight at 2.4mg versus 6% to 10% at 1mg).

For some people, the lower dose and lower cost of off-label Ozempic may be the right starting point. Others may need the higher Wegovy doses for clinically meaningful results. Your prescribing doctor can help navigate this decision.

Mounjaro Pricing

Mounjaro (tirzepatide) is TGA-approved for both type 2 diabetes and chronic weight management. It targets two receptors (GIP and GLP-1) and clinical trials showed somewhat greater average weight loss than semaglutide at equivalent doses.

Cost by Dose

| Dose | Monthly Cost (AUD) | |---|---| | 2.5mg (starter) | $285 to $349 | | 5mg | $349 to $369 | | 7.5mg | $369 to $389 | | 10mg | $389 to $399 | | 12.5mg | $399 to $415 | | 15mg (maximum) | $415 to $429 |

Annual costs at the maximum dose: roughly $4,980 to $5,148.

PBS Status

The PBAC issued a "Not Recommended" decision for Mounjaro's PBS listing in November 2024. This means Mounjaro remains entirely out-of-pocket for the foreseeable future. Eli Lilly reduced the recommended retail price for the 2.5mg starter dose to $285 per month in December 2024, a move likely aimed at improving competitive positioning against Wegovy.

Mounjaro vs Wegovy vs Ozempic: Cost Comparison

| Medication | Monthly Cost (Maintenance Dose) | Annual Cost | |---|---|---| | Ozempic (off-label, 1mg) | $180 to $220 | $2,160 to $2,640 | | Mounjaro (15mg) | $415 to $429 | $4,980 to $5,148 | | Wegovy (2.4mg) | $400 to $450 | $4,800 to $5,400 |

At maintenance doses, Mounjaro and Wegovy cost roughly the same. Off-label Ozempic is about half the price, but at a lower dose. For a full comparison of how these drugs differ in mechanism, efficacy, and side effects, see the four main GLP-1 drugs explained.

Other Weight Loss Medications: What They Cost

Saxenda (Liraglutide)

Saxenda is a daily GLP-1 injection (versus weekly for Ozempic, Wegovy, and Mounjaro). It produces more modest average weight loss (5% to 10% of body weight) and requires daily self-injection.

Cost: Approximately $380 for a pack of five pre-filled pens (roughly one month's supply at maintenance dose). Annual cost: approximately $4,560. Not PBS-listed for weight loss.

Saxenda has been largely superseded by weekly semaglutide and tirzepatide options, which are more convenient and more effective. It's still prescribed for patients who prefer liraglutide or can't tolerate semaglutide.

Xenical (Orlistat)

Orlistat is a fat-absorption blocker (a different mechanism from GLP-1 drugs). It's the most affordable option but also the least effective.

Cost: Available on PBS for approximately $7.70 (concession) or $25 (general) per script with an appropriate diagnosis. Over the counter (as Alli) at roughly $50 to $80 for a month's supply.

Weight loss on orlistat averages 3% to 5% of body weight beyond diet and exercise alone.

Contrave (Naltrexone/Bupropion)

An oral combination medication that targets appetite and cravings. Available by private prescription.

Cost: Approximately $100 to $150 per month.

Weight loss averages 5% to 8% of body weight. Works through a different mechanism (opioid antagonist plus antidepressant) and doesn't require injections.

Full Cost Comparison Table

| Medication | Type | Monthly Cost | Annual Cost | PBS Subsidy | Avg Weight Loss | |---|---|---|---|---|---| | Ozempic (PBS) | Weekly injection | $25.00 | $300 | Yes (T2D) | 6% to 10% | | Ozempic (private) | Weekly injection | $130 to $220 | $1,560 to $2,640 | No | 6% to 10% | | Wegovy | Weekly injection | $400 to $450 | $4,800 to $5,400 | Pending | 15% to 17% | | Mounjaro | Weekly injection | $415 to $429 | $4,980 to $5,148 | No | 15% to 21% | | Saxenda | Daily injection | ~$380 | ~$4,560 | No | 5% to 10% | | Contrave | Oral (daily) | $100 to $150 | $1,200 to $1,800 | No | 5% to 8% | | Xenical (PBS) | Oral (with meals) | $7.70 to $25 | $92 to $300 | Yes | 3% to 5% | | Xenical (OTC) | Oral (with meals) | $50 to $80 | $600 to $960 | No | 3% to 5% |

Weight loss percentages are approximate averages from clinical trials and represent results alongside diet and exercise interventions.

Telehealth Platform Pricing

Telehealth weight loss services bundle medication with consultations, monitoring, and support programs. The all-inclusive pricing often looks higher than pharmacy-only costs, but the comparison is complicated by the bundled services.

Juniper

Australia's largest online weight loss platform for women (operated by Eucalyptus Health, also active in the UK, Japan, and Germany).

Wegovy programme: From $349 per month (starter doses), increasing to $449 to $599 per month at higher doses.

Mounjaro programme: From $499 per month (starter), increasing to $699 to $855 per month at higher doses.

What's included: Medication supply, unlimited practitioner consultations, health tracking app, connected scales, recipes and workout guides, community access. Optional 1:1 health coaching for an additional $50 per month. No lock-in contract. 30-day money-back guarantee.

Pilot

Men's health focused (also Eucalyptus Health). Offers weight management programmes with semaglutide and tirzepatide. Pricing is broadly comparable to Juniper. Over 100,000 Australian patients.

Rosemary Health

Offers telehealth weight loss consultations with AHPRA-registered practitioners and prescription medication alongside dietitian support. Pricing structures vary; contact directly for current rates.

Telehealth vs Pharmacy: Worth the Premium?

At first glance, telehealth pricing looks $100 to $200 per month higher than buying medication directly from a pharmacy with a private prescription from your GP. The premium pays for ongoing clinical oversight, dose management, screening for contraindications, and behavioural support.

Whether this is worth it depends on your situation. If you already have a GP who's experienced with GLP-1 prescribing and willing to manage your treatment, going directly through them and filling at a pharmacy is the cheapest option. If you don't have an existing GP relationship (or your GP isn't comfortable prescribing weight loss medication), telehealth services provide a streamlined alternative.

Private Health Insurance: What's Actually Covered

Australian private health insurance provides minimal coverage for weight loss medications. The landscape has actually become more restrictive over the past year as insurers respond to surging GLP-1 demand.

Current Coverage (Examples)

| Insurer | Coverage | Limits | |---|---|---| | UniHealth | $60 per purchase | $800 annual cap (Top Extras) | | nib | Partial coverage | $150 annual sub-limit (from May 2026) | | Most other funds | Limited or none | Varies by policy |

Some private health funds offer extras cover that includes prescription medications, but the benefit amounts are typically capped at levels that barely make a dent in GLP-1 costs. A $60 benefit on a $400 Wegovy prescription saves 15%. Useful, but not transformative.

The Trend

Insurers are moving in the direction of reduced coverage, not expanded coverage. UniHealth downgraded GLP-1s from "high-cost benefit" to standard pricing. nib introduced a new annual sub-limit specifically for weight management medications. This reflects the industry's concern about the open-ended cost of covering medications that patients may take for years.

The exception could come from the employer-sponsored plan market, where some larger employers are beginning to include weight management support (including medication) as part of workplace wellness programmes. This is still uncommon in Australia but growing.

Ways to Reduce Costs

If You Have Type 2 Diabetes

The cheapest legal path to semaglutide in Australia is through the PBS. At $25 per script ($7.70 concession), annual costs are under $300. If you have type 2 diabetes and your GP hasn't discussed Ozempic, ask whether it's appropriate for your treatment plan.

For Weight Loss: Compare Pharmacies

Pricing for private prescriptions varies by $10 to $30 between pharmacy chains. Chemist Warehouse is often competitive, but calling your local Priceline and TerryWhite is worth the five minutes.

Consider Off-Label Ozempic Over Wegovy

If your doctor agrees that a lower semaglutide dose is clinically appropriate for you, off-label Ozempic at $130 to $220 per month is roughly half the cost of Wegovy. The trade-off is a lower maximum dose (1mg versus 2.4mg), which typically means less weight loss. Discuss this explicitly with your prescriber.

Use the PBS Safety Net

If you're on multiple PBS medications, track your co-payments. Once you hit the Safety Net threshold ($1,748.20 for general patients), all your PBS scripts drop to $7.70 for the rest of the calendar year.

Watch for the Wegovy PBS Listing

If you have cardiovascular disease and a BMI of 35 or above, the pending Wegovy PBS listing could reduce your costs from $400 to $450 per month to $25 per script. No confirmed date yet, but it's worth monitoring.

The Bigger Picture: Australia vs the World

Australia's PBS makes it one of the most affordable countries for diabetes patients to access semaglutide. At $25 per month, it costs a fraction of the $900 to $1,000 USD charged in the United States.

For weight loss, the picture is different. At $130 to $450 per month out of pocket, Australia sits in the mid-range globally. That's cheaper than the US (where Wegovy lists at $1,349 USD per month) but more expensive than India, where generic semaglutide launched at $15 to $55 USD per month after patent expiry. For a look at what generic pricing looks like, see generic semaglutide in India.

Australia's semaglutide patents extend well beyond India's and Canada's, so domestic generic competition isn't imminent. The most likely near-term cost relief for Australian weight loss patients will come from expanded PBS coverage (if negotiations succeed) and continued competition between Wegovy and Mounjaro driving private pricing downward.

Whatever your budget, medication is most effective when combined with behavioural strategies that address the root causes of overeating. For the evidence on why willpower-based dieting rarely works long-term, and what approaches the research supports instead, see why diets fail at the psychological level.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any medication. Pricing is approximate and subject to change. For current PBS listings and pricing, visit pbs.gov.au.

Ready to stop fighting your cravings and start reprogramming your mind for lasting success? The Hypna AI 21-day self-hypnosis program is designed to help you rewire subconscious patterns and build a healthier relationship with food from the inside out.